Skip to Content
  • Revenues ($M)
    $5,738
  • Revenue Percent Change
    5.1%
  • Profits ($M)
    $387
  • Profits Percent Change
    8.6%
  • Assets ($M)
    $3,926
  • Employees
    36,100
  • Market Value — as of March 31, 2016 ($M)
    $7,780
  • Previous Rank
    476
  • Morning Consult Brand Index
    C+

The global contract-research firm conducts clinical trials and other activities for pharmaceutical companies.

Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

CEO
Ari Bousbib
Sector
Health Care
Industry
Health Care: Pharmacy and Other Services
HQ Location
Durham, NC
Websitehttp://www.quintilesims.com
Years on Fortune 500 List3
Employees36,100
Acquired IMS Health Holdings and changed name from Quintiles Transnational Holdings.

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$5,7385.1%
Profits ($M)$3878.6%
Assets ($M)$3,926-
Total Stockholder Equity ($M)$-564-
Market Value — as of March 31, 2016 ($M)$7,780-

Profit Ratios

Profit as % of Revenues6.7%
Profits as % of Assets9.9%
Profits as % of Stockholder Equity-

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)3.08
EPS % Change (from 2014)13.2%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2015)16.6%
Total Return to Investors (5 year, annualized)-
Total Return to Investors (10 year, annualized)-